Abstract
The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes associated with lung cancer appears useful. This article is the second of a series of five and deals with hematologic, cutaneous and vascular syndromes.
Copyright © 2017 Elsevier B.V. All rights reserved.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Autoimmune Diseases / chemically induced*
-
Carcinoma, Non-Small-Cell Lung / complications
-
Female
-
Hematologic Diseases / complications
-
Hematologic Diseases / therapy
-
Humans
-
Immunotherapy / adverse effects
-
Lung Neoplasms / complications*
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / radiotherapy
-
Lung Neoplasms / surgery
-
Male
-
Middle Aged
-
Outcome Assessment, Health Care
-
Paraneoplastic Syndromes / chemically induced
-
Paraneoplastic Syndromes / immunology*
-
Skin Diseases / complications
-
Skin Diseases / immunology
-
Skin Diseases / therapy
-
Vascular Diseases / complications
-
Vascular Diseases / immunology
-
Vascular Diseases / therapy